Intellectual Property

  • December 8, 2004

    Judge Throws Out LG Electronics' Patent Lawsuit Vs. U.S., Taiwanese PC Makers

    In a decision that could represent the final blow to an aggressive licensing program by LG Electronics, a federal judge in Northern California has thrown out the Korean electronics maker’s four-year patent lawsuit against U.S. and Taiwanese makers of computers and motherboards.

  • December 7, 2004

    Chiron Sues Corus Pharma For Stealing Trade Secrets

    Biotech company Chiron has sued Seattle startup Corus Pharma, which is preparing to go public, for allegedly misappropriating trade secrets underpinning the development of an inhalable drug for cystic fibrosis.

  • December 6, 2004

    Judge Throws Out Pinpoint's Patent Lawsuit Vs. Amazon.com

    A federal judge has thrown out Pinpoint’s patent lawsuit against Amazon.com, Borders Group and other online retailers, but said the company could refile the lawsuit if it ensures that the patents are properly assigned.

  • December 6, 2004

    Federal Circuit To Hear Appeal This Week In $565M Eolas Ruling

    A panel of judges at the U.S. Court of Appeals for the Federal Circuit in Washington D.C. is scheduled to hear an appeal this week of a lower court’s decision to order Microsoft Corp. to pay $565 million in damages for infringing a patent with its Internet Explorer web browser.

  • December 6, 2004

    D.C. Circuit Rejects Mylan's Bid To Make Generic Duragesic

    A U.S. appeals court in Washington, D.C. has rejected Mylan Laboratories' bid to market a generic version of Johnson & Johnson's Duragesic pain-relief skin patch.

  • December 6, 2004

    Akamai Settles Patent Suit Vs. Cable & Wireless Unit

    Akamai Technologies Inc. has agreed to a cash settlement in its long-standing dispute with a bankrupt unit of Cable & Wireless over patents for content delivery technology, the Cambridge, Massachusetts-based company said.

  • December 6, 2004

    Mysterious Bidder Snaps Up Commerce One Patents For $15.5M

    Commerce One, a bankrupt California software company with patent rights to a number of key technical protocols for online commerce, sold its intellectual property portfolio for $15.5 million to a mysterious bidder at Monday’s closely watched auction at the U.S. Bankruptcy Court for the Northern District of California in San Francisco.

  • December 10, 2004

    McAndrews, Held & Malloy Expands With Six New Attorneys

    Chicago-based intellectual property specialty firm McAndrews, Held & Malloy has expanded its staff with six more associates, bringing the firm’s size to more than 90 attorneys and nine technology specialists.

  • December 6, 2004

    DLA Piper Rudnick Gray Cary To Become Global IP Behemoth

    Piper Rudnick’s merger with the British law firm DLA will create one of the world’s largest intellectual property practices, with well over 200 attorneys dedicated to IP.

  • December 6, 2004

    Korea's Supreme Court Throws Out Fujitsu Plasma Patent

    In a victory for Samsung Electronics, LG Electronics, Orion Electronic and Hyundai Electronics, South Korea’s Supreme Court has nullified a patent for a plasma display panel (PDP) awarded to Japanese electronics giant Fujitsu in 1995.

  • December 8, 2004

    Remy Settles Patent Suit Vs. Taiwanese Rival, But Sues Three Others In U.S.

    Auto parts maker Remy International has sued three more companies for patent infringement, shortly after settling two other patent lawsuits and dropping a third.

  • December 3, 2004

    RE/MAX International Settles Trademark Suit Vs. LendingTree

    Real estate franchise RE/MAX International, Inc. has settled its trademark lawsuit against online mortgage broker LendingTree, Inc., the two companies said.

  • December 3, 2004

    Hooters Loses Trade Dress Suit Vs. Rival Restaurant Chain

    A Florida restaurant chain that features female staff dressed in skimpy outfits did not infringe on the trade dress of the Hooters chain, a federal judge has ruled.

  • December 2, 2004

    U.S. Warns Of Legal Action Against Australian Drug Laws

    The ink has barely dried on Australia’s free trade agreement with the U.S., yet U.S. trade officials are already warning that its trading partner may face a legal challenge over laws designed to help generic competition to brand-name drugs.

  • December 2, 2004

    Energizer Prevails In Gillette's Patent Suit In Germany

    A German court has ruled for Energizer Holding’s Schick unit in rival Gillette Co.’s patent infringement lawsuit over the company’s four-bladed Quattro razor.

  • December 3, 2004

    Japan's First Private Patent Search Company Eyes April 1st Launch

    Japan’s first private patent search company, founded by industrial giants including automaker Toyota, plans to start operations on April 1st of next year.

  • December 2, 2004

    Barr Joins Challenge To Zyprexa Patent

    Three years after Barr Laboratories Inc. successfully challenged the patent on Eli Lilly’s blockbuster antidepressant Prozac, the company has set its sights on the patent for Lilly’s new top-selling drug, the anti-psychotic Zyprexa.

  • December 3, 2004

    Shire Faces Another Challenge To Patent For Adderall XR

    Another generic drug maker has launched a challenge against the patent for Shire Pharmaceuticals Group PLC’s Adderall XR, a blockbuster drug for the treatment of attention deficit and hyperactivity disorders.

  • December 2, 2004

    Judge Deals Blow To Boston Scientific In Medinol's Patent, Trade-Secret Suit

    In a stinging setback for Boston Scientific Corp., a federal judge has held that the medical device maker violated its agreements with Israel’s Medinol Ltd. when it set up a secret stent-making operation in Ireland in 1997.

  • December 1, 2004

    Judge OKs Glaxo's $75M Settlement Over Alleged Relafen Evergreening

    A federal judge has tentatively approved a $75 million settlement agreement between GlaxoSmithKline PLC and a group of consumers and third-party payors who claimed the U.K. drug maker broke antitrust law by trying to block generic competition for the arthritis drug Relafen.